alexa Meta-analysis Of The Benefits Of Inhaled Insulin In Young Diabetic Patients Above 12 Years Of Age
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics
October 17-18, 2016 Kuala Lumpur, Malaysia

Alain Ulrich Kalala Kabongo
University of South Wales, UK
Posters & Accepted Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.C1.058
Abstract
Diabetes mellitus is a major cause of death and disability. Individuals have to deal with painful injections; inhaled insulin may be beneficial for glycaemic control. The primary objective of this study was to assess the benefits of inhaled insulin for glycaemic control in insulin-dependent and insulin-resistant patients older than 12 years. ADA website, Cochrane databases, and Medline were searched for randomised clinic trials published in English between 2000 and 2003. Relevant studies were identified and selected for our review and meta-analysis. Data extractions were assessed by two reviewers. Seven randomised control trials were included, involving 1689 participants in total. Four studies included patients with type 1 diabetes and three those with type 2 diabetes. All were open label, comparing inhaled insulin to subcutaneous insulin for the duration of ≥12 weeks. There was no difference in the proportion of participants achieving HbA1C ≥7%. The estimated average relative risk was equal to 0.1420 (95% CI: -0.0313 to +0.3154). The results suggest that the benefits in the treatment group is on average 14.2% less than the risk that in the control group. The null hypothesis shows that the average true effect is equal to zero and only marginally rejected (z=1.606, p=0.108), i.e., at about 10% significance level. Statistically, the differences in results were not quite significant. Therefore, we concluded that inhaled insulin may offer similar benefits for glycaemic control compared to subcutaneous insulin for patient’s ≥12 years. Further studies are suggested regarding its benefits in diabetes-related acute and chronic events and its effectiveness alone.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords